Dr. Boumber is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
676 N Saint Clair St
Ste 850
Chicago, IL 60611Phone+1 312-695-6180Fax+1 312-695-6189
Education & Training
- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2010 - 2013
- Good Samaritan Hospital of MarylandResidency, Internal Medicine, 2007 - 2010
- UT-Houston Graduate School for Biomedical SciencesPhD, Cancer Biology and Molecular Biology, 2000 - 2005
- The University of Texas MD Anderson Cancer Center and Graduate School of Biomedical SciencesPh.D., Cancer Biology and Molecular Biology, 2000 - 2005
- Rostov State Medical UniversityClass of 1999
Certifications & Licensure
- IL State Medical License 2020 - 2026
- AL State Medical License 2023 - 2024
- PA State Medical License 2013 - 2021
- NM State Medical License 2015 - 2019
- TX State Medical License 2010 - 2013
- MD State Medical License 2009 - 2010
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Scientific Citations for Research: Google Scholar 2014
- Celgene Future Leaders in Hematology Award 2012
- Merit Award American Society of Hematology, 2011
- Join now to see all
Clinical Trials
- Single Arm on the Tolerability of Weekly Nab-paclitaxel Start of enrollment: 2013 Jun 25
- Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
- Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 6 citationsPrognostic role and biologic features of Musashi-2 expression in colon polyps and during colorectal cancer progression.Leonid V. Kharin, Igor Bychkov, Nikolay S. Karnaukhov, Mark Voloshin, Rushaniya Fazliyeva
Plos One. 2021-07-08 - 19 citationsThe role of NSD1, NSD2, and NSD3 histone methyltransferases in solid tumors.Iuliia Topchu, Rajendra P Pangeni, Igor Bychkov, Sven A Miller, Evgeny Izumchenko
Cellular and Molecular Life Sciences. 2022-05-09 - 193 citationsBiomarkers for immune checkpoint inhibition in non–small cell lung cancer (NSCLC)J. Nicholas Bodor, Yanis Boumber, Hossein Borghaei
Cancer. 2020-01-15
Journal Articles
- Epigenetic inactivation of notch-hes pathway in human B-cell acute lymphoblastic leukemiaKuang SQ, Fang Z, Zweidler-McKay PA, Yang H, Wei Y, Gonzalez-Cervantes EA, Boumber Y, Garcia-Manero G, PLoS One, 4/1/2013
- Final Report of a Randomized Study of Decitabine Versus Conventional Care for Maintenance Therapy in Patients with Intermediate and High Risk Acute Myeloid Leukemia in...Boumber Y, Kantarjian H, Jorgensen J, Faderl S, Castoro R, Autry J, Garcia-Manero G, Borthakur G, Jabbour E, Estrov Z, Cortes J, Issa JP, Ravandi F, Leukemia, 11/1/2012
- Mocetinostat (MGCD0103): a review of an isotype-specific histone deacetylase inhibitorBoumber Y, Younes A, Garcia-Manero G, Expert Opinion in Investigational Drugs, 6/1/2011
- Join now to see all
Books/Book Chapters
Lectures
- "Collaborative Translational Research Meeting"Princess Margaret Cancer Centre, Toronto - 1/1/2013
- "Cancer Epigenetics"Boston, MA - 1/1/2008
- Annual Symposium: "Stem Cells and Regenerative Medicine"Houston, TX - 1/1/2006
- Join now to see all
Press Mentions
- Tumor Mutational Burden (TMB) as a Biomarker of Response to Immunotherapy in Small Cell Lung CancerAugust 21st, 2018
- Drug Offers Some Hope for a Deadly Lung CancerApril 4th, 2017
- Shop TalkNovember 25th, 2016
- Join now to see all
Professional Memberships
- Member
- Member
Other Languages
- Russian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: